
Glimbell M 1mg/500mg Tablet SR
Marketer
Nimbles Biotech Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg)
Overview Glimbell M 1mg/500mg Tablet SR
Diabexe Duo 1mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabexe Duo should be administered with food, consistently at the same time daily for optimal effectiveness. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial; discontinuation without medical supervision can lead to elevated blood sugar, risking kidney complications, vision loss, neuropathy, and limb amputation. This medication is a component of a comprehensive diabetes management plan incorporating a balanced diet, regular physical activity, and weight management as advised by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential for prevention. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Individuals with a history of heart disease should inform their physician prior to commencing treatment. Pregnant or lactating women require medical consultation before use. Regular blood glucose monitoring is necessary, along with potential blood tests to assess blood cell counts and liver function.
Primary Ingredients of Glimbell M 1mg/500mg Tablet SR
No text provided to rephrase.
Uses of Glimbell M 1mg/500mg Tablet SR
Managing Type 2 diabetes
Major Benefits of Glimbell M 1mg/500mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimbell M 1mg/500mg Tablet SR whole; avoid chewing, crushing, or breaking it. Consume this medication with a meal.
Common Side effects of Glimbell M 1mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Glimbell M 1mg/500mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Glimbell M 1mg/500mg Tablet SR whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.
How Glimbell M 1mg/500mg Tablet SR works:
Glimbell M 1mg/500mg Extended-Release tablets combine glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar levels. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing the body's response to insulin.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimbell M 1mg/500mg SR tablets with alcohol is strongly discouraged due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Glimbell M 1mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing this medication. Seek medical advice before taking this drug.
Breast feedingUNSAFE
Extended-release Glimbell M 1mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms manifest.
KidneyCAUTION
For individuals with kidney impairment, Glimbell M 1mg/500mg Tablet SR requires careful administration and potential dose modification. Patients with severe kidney disease should avoid this medication. Close monitoring of kidney function is recommended during treatment. Physician consultation is essential.
LiverCAUTION
For individuals with liver impairment, Glimbell M 1mg/500mg SR tablets require careful administration. Dosage modification of Glimbell M 1mg/500mg SR tablets may be necessary. Medical advice is recommended. In those with mild to moderate liver disease, Glimbell M 1mg/500mg SR tablets are typically initiated at a low dose; however, their use is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Glimbell M 1mg/500mg Tablet SR :
Should you forget a Glimbell M 1mg/500mg SR tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual regimen. Avoid taking a double dose.
Facts to Know About Glimbell M 1mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
